Cervical esophageal cancer: a gap in cancer knowledge
- PMID: 27117535
- DOI: 10.1093/annonc/mdw183
Cervical esophageal cancer: a gap in cancer knowledge
Abstract
Background: The aim of this systematic review is to provide an overview of the diagnosis, treatment options and treatment-related complications of cervical esophageal carcinoma (CEC) and to subsequently provide recommendations to improve quality of care.
Design: Studies were identified in PubMed, EMBASE and Web of Science. A total of 107 publications fulfilled the inclusion criteria and were included.
Results: CEC is uncommon, accounting for 2%-10% of all esophageal carcinomas. These tumors are often locally advanced at presentation and have a poor prognosis, with a 5-year overall survival of 30%. Tobacco and alcohol consumption seem to be the major risk factors for developing CEC. Surgery is usually not possible due to the very close relationship to other organs such as the larynx, trachea and thyroid gland. Therefore, the current standard of care is definitive chemoradiation (dCRT) with curative intent. Treatment regimens used to treat CEC are adapted by established regimens in lower esophageal squamous cell carcinoma and head and neck squamous cell carcinoma. However, dCRT may be accompanied by severe side-effects and complications. Several diagnostic and predictive markers have been studied, but currently, there is no other biomarker than clinical stage to determine patient management. Suggestions to improve patient outcomes are to determine the exact radiation dose needed for adequate locoregional control and to combine radiotherapy with optimal systemic therapy backbone.
Conclusion: CEC remains unchartered territory for many practising physicians and patients with CEC have a poor prognosis. To improve the outcome for CEC patients, future studies should focus on the identification of new diagnostic biomarkers or targets for radiosensitizers, amelioration of radiation schedules, optimal combination of chemotherapeutic agents and/or new therapeutic targets.
Keywords: cervical esophageal cancer; chemoradiation; review; survival; targeted therapy; toxicity.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2. Cochrane Database Syst Rev. 2016. PMID: 27943254 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Oncologist. 2016 Jan;21(1):59-71. doi: 10.1634/theoncologist.2015-0246. Epub 2015 Dec 28. Oncologist. 2016. PMID: 26712958 Free PMC article.
-
Preoperative chemotherapy for resectable thoracic esophageal cancer.Cochrane Database Syst Rev. 2001;(1):CD001556. doi: 10.1002/14651858.CD001556. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(4):CD001556. doi: 10.1002/14651858.CD001556. PMID: 11279723 Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Surgical Outcomes of Cervical Esophageal Cancer: A Single-Center Experience.J Chest Surg. 2024 Jan 5;57(1):62-69. doi: 10.5090/jcs.23.085. J Chest Surg. 2024. PMID: 38174892 Free PMC article.
-
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study.Radiat Oncol. 2017 Jun 14;12(1):97. doi: 10.1186/s13014-017-0834-8. Radiat Oncol. 2017. PMID: 28615060 Free PMC article.
-
Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma.Front Med (Lausanne). 2021 Sep 22;8:714619. doi: 10.3389/fmed.2021.714619. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34631736 Free PMC article.
-
Efficacy and safety of endoscopic submucosal dissection for superficial cancer of the cervical esophagus.Endosc Int Open. 2017 Aug;5(8):E736-E741. doi: 10.1055/s-0043-112493. Epub 2017 Aug 7. Endosc Int Open. 2017. PMID: 28791322 Free PMC article.
-
Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma.Front Oncol. 2021 Nov 8;11:761346. doi: 10.3389/fonc.2021.761346. eCollection 2021. Front Oncol. 2021. PMID: 34820329 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous